What is Digital PCR?

Digital PCR is a powerful technique used for the direct, precise, and accurate measurement of target sequences. As a third-generation PCR method, it offers significant advantages in cancer diagnostics, relapse prediction, and minimal disease maintenance, often in conjunction with next-generation sequencing.

Would you like me to add more details on specific companies or market trends? Let me know! CLICK HERE

Top Companies in the Digital PCR Market

Several key players dominate the digital PCR market, each contributing to innovation and market growth:

⇒ Bio-Rad Laboratories, Inc.: A leader in life science and clinical diagnostic products, Bio-Rad is expanding its dPCR capabilities. In February 2025, they announced a binding offer to acquire Stilla Technologies. They also launched the Vericheck ddPCR Empty-Full Capsid Kit for AAV vector quality assessment. Expanded oncology-focused assays for ctDNA and rare mutation detection.

⇒ Thermo Fisher Scientific Inc.: This company is a major player in the market, driven by strategic acquisitions. In 2024, they acquired Combinati, adding high-resolution counting technology to their instrument suite. Launched integrated AI-powered software for workflow automation.

⇒ QIAGEN N.V.: QIAGEN is focused on expanding the capabilities of its QIAcuity digital PCR system. In January 2025, they increased the number of targets under analysis, enhancing the system's utility for dPCR applications. Strengthened infectious disease testing applications.

⇒ Sysmex Corporation: Sysmex is a key company operating in the dPCR market, contributing to its growth and development.

⇒ Merck KGaA: Merck is another significant player in the dPCR market, offering various products and solutions. Leading reagent and consumables supplier.

⇒ Stilla Technologies: Known for its Crystal Digital PCR platform, Stilla Technologies entered a U.S. distribution partnership with Avantor in July 2024. In February 2024, they closed a USD 26.5 million Series C round to accelerate commercialization. Collaborations for oncology diagnostics & multiplexing innovation.

⇒ JN Medsys: This Singapore-based company is also among the top companies in the Digital PCR market. Focused on cost-effective, compact platforms for labs in emerging markets.

⇒ Takara Bio, Inc.: Takara Bio, Inc., a Japanese biotechnology companyis a global leader in genomic research tools, PCR reagents, gene therapy vectors, and advanced molecular diagnostics. The company has steadily expanded its digital PCR (dPCR) portfolio. Expanded into clinical diagnostics in Japan & U.S.

Top Emerging Startups in 2025

» Combinati – Compact Absolute Q system (acquired by Thermo Fisher)

» Precigenome – Low-cost digital PCR systems for hospitals & labs

» Novacyt – Infectious disease-focused dPCR solutions

» Oncocyte – dPCR-based liquid biopsy diagnostics

Market Drivers

Rising demand for liquid biopsy and cancer diagnostics

Growing adoption in infectious disease monitoring (COVID-19, HIV, HBV, HCV)

Increasing use in precision medicine & companion diagnostics

Technological advances in multiplexing, automation & AI

Expanding applications in agriculture, food safety, and environmental testing

Key Market Trends

Several trends are influencing the growth and evolution of the digital PCR market:

Increasing Demand for Precision Diagnostics: The need for highly accurate genetic testing, especially in oncology and rare disease diagnostics, is driving the adoption of dPCR.

Technological Advancements: Innovations in microfluidics, chip-based systems, and user-friendly software are making dPCR more accessible and scalable .

Expanding Applications in Non-Invasive Testing: Liquid biopsy and prenatal screening are emerging as significant growth areas for dPCR-based solutions .

Rising Prevalence of Diseases: The increasing prevalence of infectious diseases, cancer, and genetic disorders is boosting the demand for dPCR.

Adoption of Droplet Digital PCR (ddPCR): ddPCR is gaining prominence due to its high sensitivity in detecting infectious diseases. Companies like Bio-Rad and Thermo Fisher are investing heavily in ddPCR platforms.

Regional Growth: North America currently holds the largest market share, while the Asia-Pacific region is expected to grow at the highest CAGR due to expanding clinical lab networks and supportive reimbursement policies

Market Segmentation

The digital PCR market can be segmented by:

Technology: Droplet Digital PCR, Chip-Based Digital PCR, Beaming Digital PCR.

Product Type: Consumables and Reagents, Digital PCR Equipment, Digital PCR Equipment.

Application: Research, Clinical Diagnostics, Forensic, Others.

End-User: Pharma and Biotech Companies, Hospitals and Clinics, Academic and Research Organizations.

Regional Outlook 2025

North America: Leading market with strong clinical adoption

Europe: Regulatory approvals driving oncology diagnostics

Asia-Pacific: Fastest growing due to infectious disease burden & genomics research investment

Frequently Asked Questions (FAQs)

Q1. What is CAGR?
13.5% worldwide.

Q2. Which industries use dPCR the most?
Healthcare, biotechnology, pharmaceuticals, agriculture, environmental monitoring.

Q3. What is the market size of the dPCR market in 2025?
Estimated USD 0.85 Billion.

Q4. What is driving the demand for dPCR?
Oncology testing, infectious diseases, personalized medicine.

Q5. Who are the top 3 players in 2025?
Bio-Rad, Thermo Fisher, QIAGEN.

Q6. What role does dPCR play in cancer diagnostics?
It enables liquid biopsy, ctDNA analysis, and rare mutation detection.

Q7. How is AI impacting dPCR?
AI enhances workflow automation, data accuracy, and predictive analytics.

Q8. Which region is growing fastest?
Asia-Pacific, due to healthcare investment and infectious disease burden.

Q9. Are startups gaining traction?
Yes, startups like Stilla Technologies & JN Medsys are disrupting with innovative, cost-effective platforms.

Q10. What is the future of dPCR?
Mainstream clinical adoption, multiplex testing, and AI-powered diagnostics.

The global digital PCR market is poised for continued expansion, driven by technological advancements, increasing applications, and the rising prevalence of various diseases. As the demand for precise and rapid testing methods grows, digital PCR will play an increasingly critical role in clinical diagnostics, research, and personalized medicine. With key players continuously innovating and expanding their offerings, the future of the dPCR market looks promising.

About US:

IMIR Market Research is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including, Semiconductor, aerospace, Automation, Agriculture, Food & Beverages, Automotive, Chemicals and Materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports.

Contact Us: IMIR Market Research Pvt. Ltd.

Email: sales@intellectualmarketinsights.com

Call Us: +1 (814) 487 8486